Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
DEPT OF DEFENSE has floated a tender for Antidote Treatment Nerve Agent Auto-Injector (Atnaa). The project location is USA and the tender is closing on 05 Jul 2023. The tender notice number is SPE2DP-23-R-0002, while the TOT Ref Number is 83996514. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Antidote Treatment Nerve Agent Auto-Injector (Atnaa)
Deadline : 05 Jul 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 83996514
Document Ref. No. : SPE2DP-23-R-0002
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Defense Logistics Agency Troop Support is seeking sources capable of providing the Antidote Treatment Nerve Agent Auto-Injector (ATNAA). DLA Troop Support is contemplating awarding a one-year base and two one-year option, indefinite quantity contract for ATNAA. The quantities to be ordered are estimated at 225, 000 units minimum and 1, 000, 000 units maximum per contract year. However, the quantity may increase or decrease as the Services requirements change.
The ATNAA shall be licensed by the Food and Drug Administration (FDA). Each auto-injector shall deliver 2.1 mg of atropine and 600mg of pralidoxime chloride in separate chambers, and be suitable for intramuscular administration.
Must have FDA approval to sell the ATNAA before award of the contract.
If your firm currently manufactures or distributes the ATNAA, please provide information with respect to the following:
a) Place of manufactureb) Estimated annual capacityc) FDA registrationd) Product name and description including description of any special featurese) Current unit sale pricef) Estimated inventory level and storage requirements
*** NEW PRODUCTS UNDER DEVELOPMENT***
For products under development, describe the current stage of development and whether the product has undergone independent laboratory testing or FDA testing/trials etc. Firms and organizations that currently develop or manufacture the ATNAA or that have technologies, pharmaceuticals, or manufacturing capabilities under development are invited to submit information to DLA Troop Support.
Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for the ATNAA. All information submitted shall remain with the U.S. Government and will not be returned. It will be kept confidential as allowed by relevant Federal law and will be eligible for a...
Active Contract Opportunity
Notice ID : SPE2DP-23-R-0002
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE LOGISTICS AGENCY (DLA)
Major Command : TROOP SUPPORT MEDICAL
Office : DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jun 06, 2023 03:21 pm EDT
Original Response Date:
Inactive Policy: Manual
Original Inactive Date: Jul 05, 2023
Initiative: None
Classification
Original Set Aside:
Product Service Code:
NAICS Code:
Place of Performance:
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google